1
Publications
29
Citations
1
H-Index
2018
Active since
Affiliations
Kailibinuer Abuduwaili is an author at Tumor Hospital of Xinjiang Medical University.
Publications per year
2018–2018
1
1
MiR-940 inhibits the progression of NSCLC by targeting FAM83F.
Gu Gm, Zhan Yy, Kailibinuer Abuduwaili et al. · PubMed · 2018 · 29 citations
Rows per page
1–1 of 1